Drug intelligence / Profile preview

methylprednisolone + mepacaine

Development stage
Unknown
Lead developer
Tanta University
Modality
Small Molecules
Administration
Intraarticular, Percutaneous
01

Overview

Methylprednisolone + mepacaine is a combination drug intervention consisting of the synthetic corticosteroid methylprednisolone and the local anesthetic mepacaine (a brand name for mepivacaine hydrochloride). Methylprednisolone functions as a glucocorticoid receptor agonist, providing potent anti-inflammatory and immunosuppressive effects to reduce tissue swelling and pain. Mepacaine acts as a local anesthetic by blocking voltage-gated sodium channels, providing rapid, short-term pain relief during and immediately after the injection. This combination is typically administered via intra-articular or percutaneous injection for the management of localized inflammatory musculoskeletal conditions such as lateral epicondylitis (tennis elbow). In clinical research, it is frequently employed as a standard-of-care active comparator to evaluate the efficacy of newer modalities like pulsed radiofrequency.

Brand names
Mepacaine
Other names
methylprednisolone and mepacainemethylprednisolone acetate + mepacaine
02

Targets

GR (Glucocorticoid receptor)NaV (Voltage-gated sodium channels)MR (Mineralocorticoid receptor)

Beyond the preview

Go deeper on methylprednisolone + mepacaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methylprednisolone + mepacaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call